Edition:
India

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

59.23USD
21 Aug 2019
Change (% chg)

$0.09 (+0.15%)
Prev Close
$59.14
Open
$59.26
Day's High
$59.38
Day's Low
$59.15
Volume
87,804
Avg. Vol
81,574
52-wk High
$69.40
52-wk Low
$33.83

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $1,462.02
Shares Outstanding(Mil.): 33.66
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 18.90 29.73 33.85
EPS (TTM): 2.30 -- --
ROI: 7.50 13.04 12.69
ROE: 12.39 14.12 17.13

Permira Funds to buy drug contract manufacturer Cambrex for $2.02 billion

Private equity firm Permira Funds will buy Cambrex Corp for about $2 billion, the drug contract development and manufacturing company said on Wednesday.

07 Aug 2019

UPDATE 1-Permira Funds to buy drug contract manufacturer Cambrex for $2.02 bln

Aug 7 Private equity firm Permira Funds will buy Cambrex Corp for about $2 billion, the drug contract development and manufacturing company said on Wednesday.

07 Aug 2019

Permira Funds to buy contract manufacturer Cambrex in $2.4 bln deal

Aug 7 Contract development and manufacturing company Cambrex Corp said on Wednesday it was being bought by an affiliate of private equity firm Permira Funds in a deal valued at about $2.4 billion, including net debt.

07 Aug 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates